Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ASCO: Childhood cancer survivors at risk of post-traumatic stress disorder

Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles, California, USA
ASCO: Childhood cancer survivors at risk of post-traumatic stress disorder ( Dr.  Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles, California, USA )
18 Jun 2009

ASCO: Maintenance therapy for NSCLC

Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO: Maintenance therapy for NSCLC ( Dr.  Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, USA )
18 Jun 2009

ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer

Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer ( Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US )
17 Jun 2009

ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC

Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC ( Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US )
17 Jun 2009

Oestrogen and progestin therapy increases NSCLC risk

Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
Oestrogen and progestin therapy increases NSCLC risk ( Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US )
17 Jun 2009

AACR 2009: Circulating tumour cells as biomarkers

Dr Howard Scher - Sloan Kettering Memorial Cancer Center
AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )
5 Jun 2009

NHS health care and the US health system

Exclusive interview with Professor Karol Sikora - Medical Director of Cancer Partners UK
NHS health care and the US health system ( Exclusive interview with Professor Karol Sikora - Medical Director of Cancer Partners UK )
28 May 2009

AACR 2009: Tackling the p53 gene and side effects

Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee
AACR 2009: Tackling the p53 gene and side effects ( Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee )
18 May 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009

AACR 2009: Chemokine inhibitors to prevent tumour growth

Prof Alberto Mantovani - Professor of General Pathology, University of Milan
AACR 2009: Chemokine inhibitors to prevent tumour growth ( Prof Alberto Mantovani - Professor of General Pathology, University of Milan )
14 May 2009

AACR 2009: Cancer stem cells and leukaemia

Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine
AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )
14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009